252 related articles for article (PubMed ID: 19662092)
1. Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype.
Røe OD; Anderssen E; Helge E; Pettersen CH; Olsen KS; Sandeck H; Haaverstad R; Lundgren S; Larsson E
PLoS One; 2009 Aug; 4(8):e6554. PubMed ID: 19662092
[TBL] [Abstract][Full Text] [Related]
2. Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets.
Røe OD; Anderssen E; Sandeck H; Christensen T; Larsson E; Lundgren S
Lung Cancer; 2010 Jan; 67(1):57-68. PubMed ID: 19380173
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
Laszlo V; Hoda MA; Garay T; Pirker C; Ghanim B; Klikovits T; Dong YW; Rozsas A; Kenessey I; Szirtes I; Grusch M; Jakopovic M; Samarzija M; Brcic L; Kern I; Rozman A; Popper H; Zöchbauer-Müller S; Heller G; Altenberger C; Ziegler B; Klepetko W; Berger W; Dome B; Hegedus B
J Pathol; 2015 Oct; 237(2):203-14. PubMed ID: 26011651
[TBL] [Abstract][Full Text] [Related]
4. Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs
Obacz J; Valer JA; Nibhani R; Adams TS; Schupp JC; Veale N; Lewis-Wade A; Flint J; Hogan J; Aresu G; Coonar AS; Peryt A; Biffi G; Kaminski N; Francies H; Rassl DM; Garnett MJ; Rintoul RC; Marciniak SJ
Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38212075
[TBL] [Abstract][Full Text] [Related]
5. The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma.
Elshazley M; Sato M; Hase T; Yamashita R; Yoshida K; Toyokuni S; Ishiguro F; Osada H; Sekido Y; Yokoi K; Usami N; Shames DS; Kondo M; Gazdar AF; Minna JD; Hasegawa Y
Int J Cancer; 2012 Dec; 131(12):2820-31. PubMed ID: 22510946
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells.
Bajaj MS; Pendurthi U; Koenig K; Pueblitz S; Idell S
Eur Respir J; 2000 Jun; 15(6):1069-78. PubMed ID: 10885426
[TBL] [Abstract][Full Text] [Related]
7. Phenotypes and karyotypes of human malignant mesothelioma cell lines.
Relan V; Morrison L; Parsonson K; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Fong KM; Bowman RV
PLoS One; 2013; 8(3):e58132. PubMed ID: 23516439
[TBL] [Abstract][Full Text] [Related]
8. Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets.
Ramírez-Salazar EG; Salinas-Silva LC; Vázquez-Manríquez ME; Gayosso-Gómez LV; Negrete-Garcia MC; Ramírez-Rodriguez SL; Chávez R; Zenteno E; Santillán P; Kelly-García J; Ortiz-Quintero B
Exp Mol Pathol; 2014 Dec; 97(3):375-85. PubMed ID: 25236577
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.
Borczuk AC; Pei J; Taub RN; Levy B; Nahum O; Chen J; Chen K; Testa JR
Cancer Biol Ther; 2016; 17(3):328-35. PubMed ID: 26853494
[TBL] [Abstract][Full Text] [Related]
10. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.
Pinelli V; Laroumagne S; Sakr L; Marchetti GP; Tassi GF; Astoul P
J Thorac Oncol; 2012 Mar; 7(3):595-8. PubMed ID: 22307010
[TBL] [Abstract][Full Text] [Related]
11. Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma.
Røe OD; Szulkin A; Anderssen E; Flatberg A; Sandeck H; Amundsen T; Erlandsen SE; Dobra K; Sundstrøm SH
PLoS One; 2012; 7(8):e40521. PubMed ID: 22905093
[TBL] [Abstract][Full Text] [Related]
12. Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma.
Soini Y; Kahlos K; Puhakka A; Lakari E; Säily M; Pääkkö P; Kinnula V
Br J Cancer; 2000 Oct; 83(7):880-6. PubMed ID: 10970689
[TBL] [Abstract][Full Text] [Related]
13. Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma.
Mairinger F; Vollbrecht C; Halbwedl I; Hatz M; Stacher E; Gülly C; Quehenberger F; Stephan-Falkenau S; Kollmeier J; Roth A; Mairinger T; Popper H
J Thorac Oncol; 2013 May; 8(5):644-53. PubMed ID: 23449276
[TBL] [Abstract][Full Text] [Related]
14. Nucleolin and nucleophosmin expression patterns in pulmonary adenocarcinoma invading the pleura and in pleural malignant mesothelioma.
Masiuk M; Waloszczyk P; Lewandowska M; Dobak E; Urasinska E
Thorac Cancer; 2020 Sep; 11(9):2529-2535. PubMed ID: 32671956
[TBL] [Abstract][Full Text] [Related]
15. In arrayed ranks: array technology in the study of mesothelioma.
Gray SG; Fennell DA; Mutti L; O'Byrne KJ
J Thorac Oncol; 2009 Mar; 4(3):411-25. PubMed ID: 19247089
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysis.
Romagnoli S; Fasoli E; Vaira V; Falleni M; Pellegrini C; Catania A; Roncalli M; Marchetti A; Santambrogio L; Coggi G; Bosari S
Am J Pathol; 2009 Mar; 174(3):762-70. PubMed ID: 19218339
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of CRISPR/Cas9-mediated NF2
Wahiduzzaman M; Karnan S; Ota A; Hanamura I; Murakami H; Inoko A; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y
Cancer Sci; 2019 Jan; 110(1):180-193. PubMed ID: 30417500
[TBL] [Abstract][Full Text] [Related]
18. Genes associated with prognosis after surgery for malignant pleural mesothelioma promote tumor cell survival in vitro.
Gordon GJ; Bueno R; Sugarbaker DJ
BMC Cancer; 2011 May; 11():169. PubMed ID: 21569526
[TBL] [Abstract][Full Text] [Related]
19. Malignant pleural mesothelioma: clinicopathology of 16 extrapleural pneumonectomy patients with special reference to early stage features.
Hiroshima K; Yusa T; Kameya T; Ito I; Kaneko K; Kadoyama C; Kishi H; Saitoh Y; Ozaki D; Itami M; Iwata T; Iyoda A; Kawai T; Yoshino I; Nakatani Y
Pathol Int; 2009 Aug; 59(8):537-45. PubMed ID: 19627537
[TBL] [Abstract][Full Text] [Related]
20. Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions.
Falleni M; Pellegrini C; Marchetti A; Roncalli M; Nosotti M; Palleschi A; Santambrogio L; Coggi G; Bosari S
Lung Cancer; 2005 May; 48(2):211-6. PubMed ID: 15829320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
